Clinical Trials List
2023-03-01 - 2029-05-01
Phase III
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Seu-Chun Yang Division of General Internal Medicine
- Chian-Wei Chen Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- 蔡政軒 Division of General Internal Medicine
- Wu-Chou Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Chin-Wei Kuo Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Inn-Wen Chong Division of Thoracic Medicine
- 郭家佑 Division of Thoracic Medicine
- 李玫萱 Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- Chih-Jen Yang Division of Thoracic Medicine
- KUAN-LI WU Division of Thoracic Medicine
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- 李柏昕 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳冠宇 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 錢穎群 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蕭慈慧 Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- Yuh-Min Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
490 participants
